Dr. Gu is Apeiron Therapeutics’ Vice President of Research and Head of Chemistry. Dr. Gu has over 20 years research and development experience in the pharmaceutical industry. Dr. Gu has been engaged in the research, development and management of novel drugs at several pharmaceutical companies and CROs, including X-Ceptor, Exelixis, ShangPharma, Otsuka and Pharmaron. Prior to joining GT Apeiron, Dr. Gu was Senior Director of R&D at the Simcere Pharmaceutical Group. Dr. Gu received his doctorate degree in organic chemistry from Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences. He completed his postdoctoral trainings at National Institutes of Health (NIH) with Dr. Kenner C. Rice as well as at McLean Hospital, Harvard Medical School, with Professor John L. Neumeyer.